| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
39,115 |
38,298 |
$1.51M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
23,834 |
23,244 |
$1.18M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
8,427 |
8,265 |
$651K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
16,122 |
15,787 |
$466K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,134 |
7,021 |
$414K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,513 |
5,418 |
$335K |
| 87634 |
|
902 |
820 |
$36K |
| 71046 |
Radiologic examination, chest; 2 views |
1,984 |
1,949 |
$32K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
76 |
75 |
$7K |
| 74018 |
|
206 |
199 |
$3K |
| 81003 |
|
1,722 |
1,693 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
16 |
15 |
$642.95 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
657 |
645 |
$448.08 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
36 |
18 |
$414.30 |
| 73610 |
|
12 |
12 |
$289.18 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
13 |
$165.72 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
12 |
$165.32 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
471 |
334 |
$145.58 |
| 99000 |
|
12 |
12 |
$122.98 |
| 82947 |
|
24 |
24 |
$76.62 |
| 94761 |
|
27 |
26 |
$41.67 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
62 |
40 |
$12.66 |